Asylia Therapeutics

Asylia Therapeutics is a private biotechnology company dedicated to translating scientific advancements into safe and effective treatments for cancer, autoimmune diseases, and infectious diseases. Founded in 2019 and headquartered in Houston, Texas, the company is led by an experienced team of entrepreneurs, scientific leaders in the fields of immunology, oncology, and clinical trials, as well as biotech executives with expertise in antibody drugs and business development.